Re: OTC Expert & Grey Market Restrictions
in response to
by
No such message found
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: OTC Expert & Grey Market Restrictions
After a quick skim, I also don't see any rules with a coming into force date on November 23, 2022:
https://www.sec.gov/rules/final.htm
Kayaker, how certain are you of this rule change?
Loading...
Loading...
New Message
Please
login
to post a reply